Dow Chemical Company’s AbbVie ABBV Stock Holding History

Dow Chemical Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-45,500	Closed	-$2.48M	–	26
2015 Q3	$2.48M	Sell	45,500 -12,000	-21%	-$781K	0.21%	51
2015 Q2	$3.86M	Hold	57,500	–	–	0.35%	38
2015 Q1	$3.37M	Hold	57,500	–	–	0.3%	43
2014 Q4	$3.76M	Sell	57,500 -20,000	-26%	-$1.26M	0.34%	37
2014 Q3	$4.48M	Sell	77,500 -15,000	-16%	-$833K	0.4%	27
2014 Q2	$5.22M	Sell	92,500 -15,000	-14%	-$787K	0.44%	27
2014 Q1	$5.53M	Buy	107,500 +54,000	+101%	+$2.73M	0.45%	21
2013 Q4	$2.83M	Hold	53,500	–	–	0.23%	42
2013 Q3	$2.39M	Sell	53,500 -8,000	-13%	-$355K	0.2%	40
2013 Q2	$2.54M	Buy	+61,500	New	+$2.69M	0.22%	38

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dow Chemical Company's ABBV Position: Q4 2015 in Review

Dow Chemical Company sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 45,500 shares — an estimated $2.48M sold.

Dow Chemical Company first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $5.53M in Q1 2014. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Dow Chemical Company reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
Dow Chemical Company sold 45,500 AbbVie shares in Q4 2015, an estimated $2.48M.
Dow Chemical Company first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
Dow Chemical Company's AbbVie position peaked at $5.53M in Q1 2014.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Dow Chemical Company's 13F filing for Q4 2015, filed 16 Feb 2016.